Skip to content
Loading your account…

MDT Medtronic plc

NYSEHealth careElectromedical & Electrotherapeutic ApparatusGalwayFY ends April 24

Profitable 5/5: Fiscal years with net income above zero, out of the last five reported.FY2026 10-K filed Jun 18, 2026 (SEC EDGAR)

FY2026 at a glance

Fundamentals from SEC filings, not quotes
Revenue
$36.4BYoYup 8.43%ended Apr 24, 2026
Net income
$4.8B13.2% margin
Diluted EPS
$3.73YoYup 3.32%
Free cash flow
$5.43B14.9% margin
Cash
$1.95BNet debt $24.2B
Total debt
$26.2BD/E 0.53×
About Medtronic plc

Overview

Medtronic plc (MDT) is listed on NYSE; the SEC classifies it under "Electromedical & Electrotherapeutic Apparatus".

For fiscal 2026 (ended Apr 24, 2026) it reported revenue of $36.36B, up 8.4% from fiscal 2025.

Net income was $4.8B, a net margin of 13.2%.

At fiscal year end it had total assets of $93.03B and stockholders' equity of $49.46B (53.2% of assets).

Fiscal years shown
FY2017–FY2026 (10 years)
Latest 10-K
Jun 18, 2026
Latest filing
8-KOct 19, 2026
FY2017–FY2026 · annual 10-K

Charts

Revenue and net income

Revenue and net income, fiscal years FY2017 to FY2026.
PeriodRevenueNet incomeNet margin
FY2017$29.7B$4.03B13.6%
FY2018$30B$3.1B10.4%
FY2019$30.6B$4.63B15.2%
FY2020$28.9B$4.79B16.6%
FY2021$30.1B$3.61B12.0%
FY2022$31.7B$5.04B15.9%
FY2023$31.2B$3.76B12.0%
FY2024$32.4B$3.68B11.4%
FY2025$33.5B$4.66B13.9%
FY2026$36.4B$4.8B13.2%

Gross, operating and net margin

Gross, operating and net margin, fiscal years FY2017 to FY2026.
PeriodGross marginOperating marginNet margin
FY201768.7%17.9%13.6%
FY201869.8%22.2%10.4%
FY201970.0%20.5%15.2%
FY202067.4%16.6%16.6%
FY202165.2%14.9%12.0%
FY202268.0%18.2%15.9%
FY202365.7%17.6%12.0%
FY202465.3%15.9%11.4%
FY202565.3%17.8%13.9%
FY202665.0%17.8%13.2%

Diluted EPS

Diluted EPS, fiscal years FY2017 to FY2026.
PeriodEPS (diluted)
FY2017$2.89
FY2018$2.27
FY2019$3.41
FY2020$3.54
FY2021$2.66
FY2022$3.73
FY2023$2.82
FY2024$2.76
FY2025$3.61
FY2026$3.73

Free cash flow vs net income

Free cash flow vs net income, fiscal years FY2017 to FY2026.
PeriodFree cash flowNet income
FY2017$5.63B$4.03B
FY2018$3.62B$3.1B
FY2019$5.87B$4.63B
FY2020$6.02B$4.79B
FY2021$4.89B$3.61B
FY2022$5.98B$5.04B
FY2023$4.58B$3.76B
FY2024$5.2B$3.68B
FY2025$5.19B$4.66B
FY2026$5.43B$4.8B

Diluted shares

Diluted shares, fiscal years FY2017 to FY2026.
PeriodDiluted shares (weighted)
FY20171.39B
FY20181.37B
FY20191.36B
FY20201.35B
FY20211.35B
FY20221.35B
FY20231.33B
FY20241.33B
FY20251.29B
FY20261.29B

Cash vs total debt

Cash vs total debt, fiscal years FY2017 to FY2026.
PeriodCash & equivalentsTotal debt
FY2017$4.97B$33.4B
FY2018$3.67B$25.8B
FY2019$4.39B$25.4B
FY2020$4.14B$24.9B
FY2021$3.59B$26.4B
FY2022$3.71B$20.4B
FY2023$1.54B$24.3B
FY2024$1.28B$25B
FY2025$2.22B$25.6B
FY2026$1.95B$26.2B

Each bar is one fiscal year as reported in its 10-K; bars below the zero line are negative and gaps are years not reported. Per-share figures are as reported, not adjusted for stock splits; comparisons across a likely split are left blank.

FY2026 · 5-year trend

Ratios

Profitability

Gross margin
65.0%
Operating margin
17.8%
Net margin
13.2%
FCF margin
14.9%
Return on equity
9.8%
Return on assets
5.2%

Growth

Growth. Compound annual growth: (end ÷ start)^(1 ÷ years) − 1, both ends positive.
Metric1y3y CAGR5y CAGR9y CAGR
Revenueup 8.43%up 5.21%up 3.84%—
EPS (diluted)up 3.32%up 9.77%up 7.00%up 2.88%
Free cash flowup 4.65%up 5.81%up 2.12%down 0.40%
Change in share count
-0.14%

Financial strength

Current ratio
2.13×
Debt / equity
0.53×
Liabilities / assets
46.2%
Net debt
$24.2B
Interest coverage
9.04×
Equity / assets
53.2%

Shareholder returns

Dividends per share
$2.84
Dividends paid
$3.64B
Buybacks
$1.04B
Payout ratio
75.8%
Stock comp. / revenue
1.3%
Piotroski F-Score · Altman Z''-Score

Quality screens

Piotroski F-Score

7 of 9 checks passed

FY2026 vs FY2025

  • PassPositive return on assets5.2%
  • PassPositive operating cash flow$7.33B
  • PassReturn on assets improved5.2% vs 5.2%
  • PassOperating cash flow above net income8.0% vs 5.2%
  • FailLong-term debt / assets fell28.1% vs 28.0%
  • PassCurrent ratio improved2.13× vs 1.85×
  • PassNo increase in share count1.29B vs 1.29B
  • FailGross margin improved65.0% vs 65.3%
  • PassAsset turnover improved0.4× vs 0.37×

Altman Z''-Score

Safe zone (above 2.60)

FY2026

Altman Z''-Score: Components
ComponentsRatioWeightPoints
Working capital / assets0.141×6.560.93
Retained earnings / assets0.351×3.261.14
Operating income / assets0.070×6.720.47
Equity / liabilities1.151×1.051.21
Z''3.75

Screening heuristic, not a recommendation. Per-share figures are as reported, not adjusted for stock splits; comparisons across a likely split are left blank.

Last 10 fiscal years · newest first

Financial statements

USD millions, except per-share figures (USD). Share counts in millions.

Income statement

Income statement. USD millions, except per-share figures (USD). Share counts in millions.
MetricFY2026Apr 24, 2026FY2025Apr 25, 2025FY2024Apr 26, 2024FY2023Apr 28, 2023FY2022Apr 29, 2022FY2021Apr 30, 2021FY2020Apr 24, 2020FY2019Apr 26, 2019FY2018Apr 27, 2018FY2017Apr 28, 2017
Revenue36,36433,53732,36431,22731,68630,11728,91330,55729,95329,710
YoY (Revenue)+8.43%+3.62%+3.64%-1.45%+5.21%+4.16%-5.38%—+0.82%—
Gross profit23,64321,90521,14820,50821,54119,63419,48921,40220,89820,419
Selling, general & admin.11,78410,84910,73610,41510,29210,14810,10910,4189,9749,711
Operating income6,4675,9555,1445,4855,7524,4844,7916,2686,6515,330
Interest expense7157297196365539251,0921,4441,1461,094
Pretax income6,1365,6284,8375,3645,5173,8954,0555,1975,6754,602
Income tax1,2999361,1331,580456265-7515472,580578
Net income4,8014,6623,6763,7585,0393,6064,7894,6313,1044,028
YoY (Net income)+2.98%+26.82%-2.18%-25.42%+39.74%-24.70%+3.41%+49.19%-22.94%—
EPS (basic)3.753.632.772.833.752.683.573.442.292.92
EPS (diluted)3.733.612.762.823.732.663.543.412.272.89
YoY (EPS (diluted))+3.32%+30.80%-2.13%-24.40%+40.23%-24.86%+3.81%+50.22%-21.45%—
Diluted shares (weighted)1,2881,2901,3301,3331,3511,3541,3511,3581,3681,391

Balance sheet

Balance sheet. USD millions, except per-share figures (USD). Share counts in millions.
MetricFY2026Apr 24, 2026FY2025Apr 25, 2025FY2024Apr 26, 2024FY2023Apr 28, 2023FY2022Apr 29, 2022FY2021Apr 30, 2021FY2020Apr 24, 2020FY2019Apr 26, 2019FY2018Apr 27, 2018FY2017Apr 28, 2017
Cash & equivalents1,9492,2181,2841,5433,7143,5934,1404,3933,6694,967
Receivables6,6436,5156,1285,9985,5515,4624,6456,2225,9875,591
Inventory5,9515,4765,2175,2934,6164,3134,2293,7533,5793,338
Current assets24,78723,81421,93521,67523,05922,54822,03121,96722,98024,873
Goodwill42,58741,73740,98641,42540,50241,96139,84139,95939,54338,515
Intangible assets10,14611,66713,22514,84415,59517,74019,06320,56021,72323,407
Total assets93,02891,68089,98190,94890,98193,08390,68989,69491,39399,816
Current liabilities11,65812,87910,7899,05112,3948,50910,3668,47210,08414,220
Short-term debt—01,073———2,7768382,0587,494
Long-term debt26,17325,64223,93224,34420,37226,37822,14024,55223,69225,874
Total liabilities42,95643,42439,56139,28338,26041,48139,81739,48240,57149,400
Retained earnings32,63831,47630,40330,39230,25028,59428,13226,27024,37923,356
Stockholders' equity49,46348,02450,21451,48352,55151,42850,73750,09150,72050,294
Shares outstanding1,2801,2821,3111,3311,3311,3451,3411,3411,3541,369

Cash flow

Cash flow. USD millions, except per-share figures (USD). Share counts in millions.
MetricFY2026Apr 24, 2026FY2025Apr 25, 2025FY2024Apr 26, 2024FY2023Apr 28, 2023FY2022Apr 29, 2022FY2021Apr 30, 2021FY2020Apr 24, 2020FY2019Apr 26, 2019FY2018Apr 27, 2018FY2017Apr 28, 2017
Operating cash flow7,3307,0446,7876,0397,3466,2407,2347,0074,6846,880
Capital expenditures1,9041,8591,5871,4591,3681,3551,2131,1341,0681,254
Free cash flow5,4265,1855,2004,5805,9784,8856,0215,8733,6165,626
YoY (Free cash flow)+4.65%-0.29%+13.54%-23.39%+22.37%-18.87%+2.52%+62.42%-35.73%—
Depreciation & amortization2,9582,8612,6472,6972,7072,7022,6632,6592,6442,917
Stock-based compensation457429393355359344297290344348
Share repurchases1,0353,2352,1386452,5446521,3262,8772,1713,544
Dividends paid3,6393,5893,6663,6163,3833,1202,8942,6932,4942,376
Dividends per share2.842.802.762.722.522.322.162.001.841.72
Key financials (annual, 10-K)

Values as reported in each fiscal year's Form 10-K (XBRL data on SEC EDGAR); growth and ratios are computed from those values. Revenue is the total revenue figure the company tagged (omitted when the only figure tagged is evidently partial, e.g. below net income); growth is only shown between consecutive ~12-month fiscal years reported with the same revenue measure. Per-share figures and share counts are as reported and not adjusted for later stock splits. — = not reported.

FY2026 · per diluted weighted share

Per share and valuation context

EPS (diluted)
$3.73
Revenue per share
$28.23
FCF per share
$4.21
Book value per share
$38.40
Tangible book per share
-$2.54
Cash per share
$1.51
Dividends per share
$2.84
Public floatas of Oct 24, 2025
$120B

Price ratios need a live quote. This page shows no stock prices. Per-share figures are as reported, not adjusted for stock splits; comparisons across a likely split are left blank.

Price ratio calculator

Type a share price to compute ratios from the latest 10-K figures. Nothing is stored or sent. (FY2026)

Market capPrice × diluted weighted shares
—
P/EPrice ÷ diluted EPS
—
P/BPrice ÷ book value per share
—
P/SPrice ÷ revenue per share
—
P/FCFPrice ÷ FCF per share
—
Dividend yieldDividends per share ÷ price
—
SEC EDGAR

Filing timeline

  1. 8-K
    Current report· Oct 15, 2026(SEC EDGAR)
    • 5.02Officer or director changes
    • 5.07Shareholder vote results
    • 7.01Regulation FD disclosure
    • 9.01Financial statements and exhibits
  2. 8-K
    Current report· Sep 17, 2026(SEC EDGAR)
    • 8.01Other events
    • 9.01Financial statements and exhibits
  3. 10-Q
    Quarterly report· Jul 31, 2026(SEC EDGAR)
  4. 8-K
    Current report· Sep 1, 2026(SEC EDGAR)
    • 2.02Results of operations
    • 9.01Financial statements and exhibits
  5. DEF 14A
    Proxy statement· Oct 15, 2026(SEC EDGAR)
  6. 10-K
    Annual report· Apr 24, 2026(SEC EDGAR)
  7. 8-K
    Current report· Jun 3, 2026(SEC EDGAR)
    • 2.02Results of operations
    • 9.01Financial statements and exhibits
  8. 8-K
    Current report· May 18, 2026(SEC EDGAR)
    • 5.02Officer or director changes
    • 9.01Financial statements and exhibits
  9. 8-K
    Current report· Apr 24, 2026(SEC EDGAR)
    • 7.01Regulation FD disclosure
    • 9.01Financial statements and exhibits
  10. 8-K
    Current report· Mar 24, 2026(SEC EDGAR)
    • 7.01Regulation FD disclosure
All filings on SEC EDGAR

Frequently asked questions

What does Medtronic plc do?

The SEC classifies Medtronic plc under Standard Industrial Classification (SIC) code 3845, "Electromedical & Electrotherapeutic Apparatus". It is headquartered in Galway. In fiscal 2026 it reported revenue of $36.36B and net income of $4.8B in its annual 10-K report.

What was Medtronic plc's revenue in 2026?

Medtronic plc reported revenue of $36.36B for fiscal 2026, which ended Apr 24, 2026, up 8.4% from $33.54B in fiscal 2025, according to its annual 10-K report filed with the SEC on Jun 18, 2026.

What was Medtronic plc's net income in 2026?

Medtronic plc reported net income of $4.8B for fiscal 2026, a net margin of 13.2% of revenue.

Where is Medtronic plc listed?

According to the SEC, Medtronic plc's ticker MDT is listed on NYSE.

When does Medtronic plc's fiscal year end?

According to the SEC, Medtronic plc's fiscal year ends on April 24; its latest reported fiscal year (2026) ended Apr 24, 2026.

Source: SEC EDGAR · Last updated:

Ver en español

Not investment advice: This page shows financial data that companies reported to the US Securities and Exchange Commission, for information only. It is not investment advice or a recommendation to buy or sell any security, and it shows no stock prices. Data may be incomplete, restated or out of date — check the original filings on SEC EDGAR before making decisions.